Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zymeworks
Biotech
BMS calls time on Zymeworks collab, ending work on bispecific
The decision was made "as part of our ongoing prioritization efforts," a BMS spokesperson told Fierce.
James Waldron
Apr 30, 2026 10:22am
Former TreeFrog CEO leaps to Orano Med—Chutes & Ladders
Apr 10, 2026 8:30am
RFK Jr. continues overhaul of CDC vaccine panel—Chutes & Ladders
Jan 16, 2026 8:30am
Gilead abruptly parts ways with general counsel—Chutes & Ladders
Nov 21, 2025 8:30am
Former CBER chief Peter Marks leaps to Lilly—Chutes & Ladders
Oct 10, 2025 8:30am
Zymeworks drops clinical-stage TCE over benefit-risk profile
Sep 2, 2025 8:10am
